Thynk Health, LLC

Based in the US, Thynk Health operates as a healthcare technology provider offering AI-driven cancer screening and incidental findings management solutions for healthcare institutions. The company focuses on automating clinical workflows, improving early disease detection, and enhancing patient outcomes through data-driven analytics. Based in Kentucky, United States and founded in 2014, Thynk Health, LLC, fka MedMyne and Elite Rad Reporting, founded by Harold Reedy, Joey Bargo, and Kevin Croce provides AI-based healthcare software solutions for the digital health and oncology screening industry. The company develops platforms to automate lung cancer screening and incidental findings management for healthcare providers.

In April 2026, Azra AI, a portfolio company of SJF Ventures, acquired Thynk Health, LLC. Thynk Health offers a cloud-based platform that enables early detection, tracking, and follow-up of lung cancer and incidental findings using artificial intelligence. Its solutions include automated workflow tools, patient communication systems, and clinical analytics to support screening programs across multiple organ systems. The company primarily generates revenue through licensing and subscription fees for its SaaS-based healthcare platform used by hospitals and healthcare providers.

Additional revenue may come from enterprise deployments, analytics solutions, and ongoing support services tied to its screening and patient management software.